Agustin, Alfredo A.

HRN: 02-10-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/09/2025
09/15/2025
IV
2.25
Q6
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractBloodstream    Compliance to guidelines: Compliant To Guidelines